Clinical characteristics | Patients (n = 5181) |
---|---|
BMI (kg/m2), Mean ± SD | 27.7 ± 6.0 |
BMI group (n, %) | |
< 24 kg/m2 | 978 (18.9) |
24–28 kg/m2 | 2363 (45.6) |
≥ 28 kg/m2 | 1840 (35.5) |
Central Obesity (n, %) | 3720 (71.8) |
Duration of NAFLD (mo), Mean ± SD | 36.8 ± 46.5 |
Disease severity (n, %) | |
Simple fatty liver | 4661 (90.0) |
NASH | 187 (3.6) |
Cirrhosis | 28 (0.5) |
Unknown | 305 (5.9) |
Complications (n, %) | |
Diabetes | 801 (15.5) |
Hypertension | 1191 (23.0) |
Hyperlipidemia | 1955 (37.7) |
Cardiovascular disease | 414 (8.0) |
Depression | 135 (2.6) |
Colon disease | 115 (2.2) |
Duration of ongoing treatment (mo), Mean ± SD | 12.9 ± 25.9 |
Laboratory examination, Mean ± SD | |
ALT (U/L) | 53.2 ± 47.0 |
TG (mmol/L) | 2.4 ± 2.1 |